Management of Gram-negative and fungal endocarditis

International Journal of Antimicrobial Agents

Volumn 36, Issue SUPPL. 2, 2010, Pages

  Durante Mangoni, Emanuele ^a   Tripodi, Marie Franoise ^a   Albisinni, Rosina ^a   Utili, Riccardo ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Antifungal agents; Antimicrobial agents; Candida spp.; Cardiac surgical procedure; Gram negative bacteria; Infective endocarditis

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; AMPICILLIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CASPOFUNGIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CILASTATIN PLUS IMIPENEM; CIPROFLOXACIN; CLINDAMYCIN; COLISTIN; COTRIMOXAZOLE; FLUCONAZOLE; GENTAMICIN; ITRACONAZOLE; MEROPENEM; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULTAMICILLIN; TIMENTIN; TOBRAMYCIN;

ACHROMOBACTER XYLOSOXIDANS; ACINETOBACTER BAUMANNII; AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL ENDOCARDITIS; BLOOD CULTURE; CARDIOBACTERIUM HOMINIS; DRUG CHOICE; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EIKENELLA CORRODENS; ESCHERICHIA COLI; FUNGAL ENDOCARDITIS; GRAM NEGATIVE INFECTION; HAEMOPHILUS; HEART ABSCESS; HOSPITAL INFECTION; HUMAN; KINGELLA KINGAE; KLEBSIELLA; NONHUMAN; POLYNEUROPATHY; PRIORITY JOURNAL; PROSTHETIC VALVE ENDOCARDITIS; PSEUDOMONAS AERUGINOSA; RECOMMENDED DRUG DOSE; STENOTROPHOMONAS MALTOPHILIA;

ANTI-INFECTIVE AGENTS; CROSS INFECTION; ENDOCARDITIS; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; MYCOSES; PREVALENCE;

EID: 78650222927     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.11.012     Document Type: Article

References (49)

1. K. Gould, C.H. Ramirez-Ronda, R.K. Holmes, and J.P. Sanford Adherence of bacteria to heart valves in vitro J Clin Invest 56 1975 1364 1370
2. P. Moreillon, and Y.A. Que Infective endocarditis Lancet 363 2004 139 149
3. A. Contrepois, J.M. Vallois, J.J. Garaud, B. Pangon, J. Mohler, and A. Meulemans Kinetics and bactericidal effect of gentamicin and latamoxef (moxalactam) in experimental Escherichia coli endocarditis J Antimicrob Chemother 17 1986 227 237
4. E. Durante-Mangoni, S. Bradley, C. Selton-Suty, M.F. Tripodi, B. Barsic, and E. Bouza Current features of infective endocarditis in the elderly: results of the International Collaboration on Endocarditis prospective cohort study Arch Intern Med 168 2008 2095 2103
5. D.R. Murdoch, G.R. Corey, B. Hoen, J.M. Miró, V.G. Fowler Jr., and A.S. Bayer Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis Prospective Cohort Study Arch Intern Med 169 2009 463 473
6. M.P. Reyes, and K.C. Reyes Gram-negative endocarditis Curr Infect Dis Rep 10 2008 267 274
7. M. Falcone, N. Barzaghi, G. Carosi, P. Grossi, L. Minoli, and V. Ravasio Candida infective endocarditis: report of 15 cases from a prospective multicenter study Medicine (Baltimore) 88 2009 160 168
8. J.W. Baddley, D.K. Benjamin Jr., M. Patel, J. Miró, E. Athan, and B. Barsic Candida infective endocarditis Eur J Clin Microbiol Infect Dis 27 2008 519 529
9. S. Morpeth, D. Murdoch, C.H. Cabell, A.W. Karchmer, P. Pappas, and D. Levine Non-HACEK Gram-negative bacillus endocarditis Ann Intern Med 147 2007 829 835
10. M. Das, A.D. Badley, F.R. Cockerill, J.M. Steckelberg, and W.R. Wilson Infective endocarditis caused by HACEK microorganisms Annu Rev Med 48 1997 25 33
11. P. Brouqui, and D. Raoult Endocarditis due to rare and fastidious bacteria Clin Microbiol Rev 14 2001 177 207
12. A.N. Malani, D.M. Aronoff, S.F. Bradley, and C.A. Kauffman Cardiobacterium hominis endocarditis: two cases and a review of the literature Eur J Clin Microbiol Infect Dis 25 2006 587 595
13. S.T. Huang, H.C. Lee, N.Y. Lee, K.H. Liu, and W.C. Ko Clinical characteristics of invasive Haemophilus aphrophilus infections J Microbiol Immunol Infect 38 2005 271 276
14. L. Paturel, J.P. Casalta, G. Habib, M. Nezri, and D. Raoult Actinobacillus actinomycetemcomitans endocarditis Clin Microbiol Infect 10 2004 98 118
15. N. el Khizzi, S.A. Kasab, and A.O. Osoba HACEK group endocarditis at the Riyadh Armed Forces Hospital J Infect 34 1997 69 74
16. K. Westling, and M. Vondracek Actinobacillus (Aggregatibacter) actinomycetemcomitans (HACEK) identified by PCR/16S rRNA sequence analysis from the heart valve in a patient with blood culture negative endocarditis Scand J Infect Dis 40 2008 981 983
17. M.P. Tornos, B. Almirante, A. Pahissa, A.M. Planes, and J.M. Martinez-Vásquez Prosthetic valve endocarditis caused by Gram-negative bacilli of the HACEK group Am J Med 88 1990 64N
18. D.J. Meyer, and D.N. Gerding Favorable prognosis of patients with prosthetic valve endocarditis caused by Gram-negative bacilli of the HACEK group Am J Med 85 1988 104 107
19. K.C. Kugler, D.J. Biedenbach, and R.N. Jones Determination of the antimicrobial activity of 29 clinically important compounds tested against fastidious HACEK group organisms Diagn Microbiol Infect Dis 34 1999 73 76
20. L.M. Baddour, W.R. Wilson, A.S. Bayer, V.G. Fowler Jr., A.F. Bolger, and M.E. Levison Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications Circulation 111 2005 e394 e434
21. G. Habib, B. Hoen, P. Tornos, F. Thuny, B. Prendergast, and I. Vilacosta Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC) Eur Heart J 30 2009 2369 2413
22. S. Branger, J.P. Casalta, G. Habib, F. Collard, and D. Raoult Escherichia coli endocarditis: seven new cases in adults and review of the literature Eur J Clin Microbiol Infect Dis 24 2005 537 541
23. M.L. Fernandez Guerrero, J.M. Aguado, A. Arribas, C. Lumbreras, and M. de Gorgolas The spectrum of cardiovascular infections due to Salmonella enterica Medicine (Baltimore) 83 2004 123 138
24. M.S. Ahmed, C. Nistal, R. Jayan, M. Kuduvalli, and H.K. Anijeet Achromobacter xylosoxidans, an emerging pathogen in catheter-related infection in dialysis population causing prosthetic valve endocarditis: a case report and review of literature Clin Nephrol 71 2009 350 354
25. M. Wieland, M.M. Lederman, C. Kline-King, T.F. Keys, P.I. Lerner, and S.N. Bass Left-sided endocarditis due to Pseudomonas aeruginosa. A report of 10 cases and review of the literature Medicine (Baltimore) 65 1986 180 189
26. P.J. Gavin, M.T. Suseno, F.V. Cook, L.R. Peterson, and R.B. Thomson Jr. Left-sided endocarditis caused by Pseudomonas aeruginosa: successful treatment with meropenem and tobramycin Diagn Microbiol Infect Dis 47 2003 427 430
27. N.F. Crum, G.C. Utz, and M.R. Wallace Stenotrophomonas maltophilia endocarditis Scand J Infect Dis 34 2002 925 927
28. J.H. Kim, S.W. Kim, H.R. Kang, G.B. Bae, J.H. Park, and E.J. Nam Two episodes of Stenotrophomonas maltophilia endocarditis of prosthetic mitral valve: report of a case and review of the literature J Korean Med Sci 17 2002 263 265
29. N.J. Mehta, I.A. Khan, R.N. Mehta, and A. Gulati Stenotrophomonas maltophilia endocarditis of prosthetic aortic valve: report of a case and review of literature Heart Lung 29 2000 351 355
30. R.G. Munter, A.M. Yinnon, Y. Schlesinger, and C. Hershko Infective endocarditis due to Stenotrophomonas (Xanthomonas) maltophilia Eur J Clin Microbiol Infect Dis 17 1998 353 356
31. T. Menon, S. Shanmugasundaram, B. Nandhakumar, K. Nalina, and Balasubramaniam Infective endocarditis due to Acinetobacter baumannii complex: a case report Indian J Pathol Microbiol 49 2006 576 578
32. A.S. Malik Acinetobacter endocarditis in children: a case report and review of the literature Infection 23 1995 306 308
33. S. Gorbach, and J. Bartlett Anaerobic infections N Engl J Med 290 1974 1177 1184 1237-45, 1289-94
34. C. Nord Anaerobic bacteria in septicemia and endocarditis Scand J Infect Dis 11 1982 95 104
35. N. Bisharat, L. Goldstein, R. Raz, and M. Elias Gram-negative anaerobic endocarditis: two case reports and review of the literature Eur J Clin Microbiol Infect Dis 20 2001 651 654
36. K. Kapoor, M. Chandra, D. Nag, J. Paliwal, R. Gupta, and R. Saxena Evaluation of metronidazole toxicity: a prospective study Int J Clin Pharmacol Res 19 1999 82 88
37. L.C. Pierrotti, and L.M. Baddour Fungal endocarditis, 1995-2000 Chest 122 2002 302 310
38. D.K. Benjamin Jr., J.M. Miró, B. Hoen, W.J. Steinbach, V.G. Fowler Jr., and L. Olaison Candida endocarditis: contemporary cases from the International Collaboration of Infectious Endocarditis Merged Database (ICE-MD) Scand J Infect Dis 36 2004 453 455
39. W.J. Steinbach, J.R. Perfect, C.H. Cabell, V.G. Fowler, G.R. Corey, and J.S. Li A meta-analysis of medical versus surgical therapy for Candida endocarditis J Infect 51 2005 230 247
40. V. Moudgal, T. Little, D. Boikov, and J.A. Vazquez Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis Antimicrob Agents Chemother 49 2005 767 769
41. G. Ramage, K. VandeWalle, S.P. Bachmann, B.L. Wickes, and J.L. Lopez-Ribot In vitro pharmacodynamic properties of three antifungal agents against preformed Candida albicans biofilms determined by time-kill studies Antimicrob Agents Chemother 46 2002 3634 3636
42. D.M. Kuhn, T. George, J. Chandra, P.K. Mukherjee, and M.A. Ghannoum Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins Antimicrob Agents Chemother 46 2002 1773 1780
43. S.P. Bachmann, K. VandeWalle, G. Ramage, T.F. Patterson, B.L. Wickes, and J.R. Graybill In vitro activity of caspofungin against Candida albicans biofilm Antimicrob Agents Chemother 46 2002 3591 3596
44. A. Katragkou, A. Chatzimoschou, M. Simitsopoulou, M. Dalakiouridou, E. Diza-Mataftsi, and C. Tsantali Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms Antimicrob Agents Chemother 52 2008 357 360
45. M.J. Jimenez-Exposito, G. Torres, A. Baraldes, N. Benito, F. Marco, and J.C. Paré Native valve endocarditis due to Candida glabrata treated without valvular replacement: a potential role for caspofungin in the induction and maintenance treatment Clin Infect Dis 39 2004 e70 e73
46. R. Rajendram, N.J. Alp, A.R. Mitchell, I.C.J.W. Bowler, and J.C. Forfar Candida prosthetic valve endocarditis cured by caspofungin therapy without valve replacement Clin Infect Dis 40 2005 e72 e74
47. D.C. Lye, A. Hughes, D. OBrien, and E. Athan Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review Eur J Clin Microbiol Infect Dis 24 2005 753 755
48. V. Bacak, B. Biocina, B. Starcevic, S. Gertler, and J. Begovac Candida albicans endocarditis treatment with caspofungin in an HIV-infected patient - case report and review of literature J Infect 53 2006 e11 e14
49. P.G. Pappas, C.A. Kauffman, D. Andes, D.K. Benjamin Jr., T.F. Calandra, and J.E. Edwards Jr. Clinical practice guidelines for the management of candidiasis Clin Infect Dis 48 2009 503 535